HK inno.N licenses in GLP-1 analog from Chinese biotech |

HK inno.N, a Korean pharmaceutical company, announced its strategic entry into the rapidly growing global obesity treatment market through a partnership with Sciwind Biosciences, a Chinese biotech firm.

HK inno.N CEO Kwak Dal-won (left) and Sciwind CEO Hai Pan hold up the license agreement at Sciwind R&D Center in Beijing, China, on Tuesday. (credit: HK inno.N)

This collaboration is centered around the development and commercialization of Sciwind Biosciences’ glucagon-like…
Read More…

Source: https://www.koreabiomed.com/news/articleViewAmp.html?idxno=23952

Scientists Harness Wild Soybean Traits with New Biotech Tool

Researchers found a method to domesticate wild soybeans for better crop resistance and agricultural productivity.

A team at Purdue University, with soybean geneticist Jianxin Ma at the helm, has created a pioneering biotechnological tool aimed at harnessing desirable traits from wild soybeans, such as increased resistance to leafhopper pests. This method, known as de novo domestication, streamlines the process of engineering crop improvements directly from nature’s untamed…
Read More…

Source: https://www.seedworld.com/us/2024/05/01/scientists-harness-wild-soybean-traits-with-new-biotech-tool/

Pathways to Commercializing Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialization strategy. Once a technology has been developed and proven, the organization must then embark on a process to commercialize it for revenue generation. The strategy a company leverages to pursue commercialization is a crucial ingredient in building a successful and profitable venture. Investors would do well to understand the…
Read More…

Source: https://investingnews.com/pathways-to-commercializing-biotech-innovations/

Moderna exits Metagenomi gene editing deal worth $3B biobucks – Fierce Biotech

Moderna exits Metagenomi gene editing deal worth $3B biobucks Fierce BiotechModerna breaks off deal with CRISPR company Metagenomi STATMetagenomi to regain full development rights to its wholly-owned base editing and RIGS systems GlobeNewswire
Read More…

Source: https://www.fiercebiotech.com/biotech/moderna-exits-gene-editing-deal-worth-3b-biobucks-leaving-metagenomi-spotlight

Biotechnology critical to addressing food security, says minister – TheCable

Biotechnology critical to addressing food security, says minister TheCableFG Confident Of NBMA’s Regulation Of Modern Biotech Science NigeriaWithout science, innovation, food security cannot be achieved — NBRDA Tribune OnlineAdvancement in biotechnology ushering new era of agricultural productivity — NBRD – EnviroNews – latest environment news, climate change, renewable energy EnviroNews NigeriaStakeholders meet to address concerns over biotech crops Daily…
Read More…

Source: https://www.thecable.ng/biotechnology-critical-to-addressing-food-security-says-minister/

Malin Investee Poseida Forges Major Biotech Alliance

Malin Corporation PLC (MLLNF) has released an update.
Malin Corporation PLC has announced that its investee, Poseida Therapeutics, entered a significant research collaboration and licensing deal with Xyphos Biosciences, aiming to develop innovative CAR-T therapies for solid tumors. Poseida is set to receive an upfront payment of $50 million, with the potential for up to $550 million in additional milestones and royalties. The partnership marries Poseida’s allogeneic CAR-T platform with…
Read More…

Source: https://www.tipranks.com/news/company-announcements/malin-investee-poseida-forges-major-biotech-alliance

Atlanta’s Biotech Scene Prepares for New Heights

Pictured: Skyline of Atlanta iStock/Kruck20

A new project has capped off construction in Midtown Atlanta, providing physical real estate that experts say is sorely needed for the region’s growing biotech ecosystem, now home to more than 4,000 life science companies.

The Science Square project completed the first phase of construction last week. Built by real estate developer Trammell Crow and Georgia Advanced Technology Ventures, an affiliate of the Georgia Institute of…
Read More…

Source: https://www.biospace.com/article/atlanta-s-biotech-scene-prepares-for-new-heights-as-new-projects-start-to-open/

Burges Salmon advises Edinburgh-based biotech on investment

Burges Salmon has advised Calcivis, a Scottish biotech that aims to revolutionise early-intervention diagnostics in dentistry, on its £5 million investment. The funding was provided by the Scottish National Investment Bank and IFS Maven Equity Finance, which is managed by Maven Capital Partners and is part of the Investment Fund for Scotland, delivered by the British Business Bank. The Burges Salmon team advising Calcivis was led…
Read More…

Source: https://www.scottishlegal.com/articles/burges-salmon-advises-edinburgh-based-biotech-on-investment

Admiral William McRaven to Keynote 2024 BIO Convention

Retired U.S. Navy (SEAL) Four-Star Admiral and the Former Chancellor of The University of Texas System, William McRaven, to Discuss Leadership, Global Events, and the National Security Importance of Biotechnology with BIO CEO, John Crowley

WASHINGTON, April 30, 2024 /PRNewswire/ — As recent global events have demonstrated, the world has become more challenging and American leadership is needed more at home and abroad than ever before, and that includes maintaining U.S. dominance in…
Read More…

Source: https://www.biospace.com/article/releases/admiral-william-mcraven-to-keynote-2024-bio-convention/

“The government’s push towards making India a hub for biotech through various schemes has positively impacted the sector”

With pharma, biotech, and healthcare on an ever-growing trajectory, the demand for medicines, diagnostic equipment, and sophisticated laboratory and analytical instruments has surged. In tandem, Bio Supplier Industry is experiencing remarkable growth with increased investment in Research and Development (R&D). Not just investments in R&D, emergence of new advancements like Artificial Intelligence, and adaptation of cloud computing are fast driving growth exponentially. In an…
Read More…

Source: https://www.biospectrumindia.com/views/17/24557/the-governments-push-towards-making-india-a-hub-for-biotech-through-various-schemes-has-positively-impacted-the-sector.html